Cancer screening is very important today because early detection can significantly increase the chances of successful treatment. One medical innovation gaining attention is the SPOT-MAS (Specific Peptides for Onco Target-Metabolic Activity Screening) test, an effective new method for detecting cancer cells in the body.
SPOT-MAS uses specific proteins or peptides to detect the metabolic activity of cancer cells in the body. Cancer cells often exhibit clear changes from normal cells, allowing for detection in the early stages, which positively impacts treatment outcomes.
The SPOT-MAS test can screen for a wide range of cancers, including:
The SPOT-MAS test begins with a blood draw to collect a blood sample from the patient. This step is for collecting the blood sample to analyze the levels of various proteins and biochemical substances that may be associated with cancer, such as proteins related to the growth of cancer cells and proteins affecting the body's immune system.
After the blood sample is collected, **advanced technology** is used to inspect and analyze the proteins through a highly precise and accurate system, specifically detecting **Tumor Markers** present in the blood, which may be an initial sign of cancer development. Additionally, other important proteins are analyzed to indicate cellular abnormalities in the body.
This analysis procedure can effectively help **detect cancer-related abnormalities in the early stages**, allowing the doctor to plan appropriate treatment, including selecting targeted therapy methods and monitoring the patient's condition in the future.
SPOT-MAS is a modern, non-invasive cancer screening method that effectively increases the chance of successful early-stage cancer treatment.
